| P50 | author | Giovanni Iolascon | Q47117751 |
| P2093 | author name string | Carla Caffarelli | |
| | Ranuccio Nuti | |
| | Stefano Gonnelli | |
| | Francesco Bertoldo | |
| | Aurora Patti | |
| | Giulia Letizia Mauro | |
| P2860 | cites work | Zoledronic acid and clinical fractures and mortality after hip fracture | Q34689802 |
| | Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. | Q35504164 |
| | Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study | Q35554696 |
| | Pathogenesis of osteoporotic hip fractures | Q35702005 |
| | Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records | Q36486940 |
| | Secular trends in the incidence of hip and other osteoporotic fractures. | Q36537168 |
| | An estimate of the worldwide prevalence and disability associated with osteoporotic fractures | Q36597363 |
| | Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. | Q38029296 |
| | Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011. | Q38406972 |
| | Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention | Q38460169 |
| | Undertreatment with anti-osteoporotic drugs after hospitalization for fracture | Q38481593 |
| | Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study | Q40313121 |
| | Guidelines for the diagnosis, prevention and management of osteoporosis | Q40684283 |
| | Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis | Q40768242 |
| | Prevention of hip fractures: risk factor modification | Q40883652 |
| | Mortality and morbidity associated with osteoporosis drug treatment following hip fracture | Q44540755 |
| | Low incidence of anti-osteoporosis treatment after hip fracture | Q44814174 |
| | Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system. | Q48923386 |
| | Medication use before and after hip fracture: a population-based cohort and case-control study. | Q51140318 |
| | Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. | Q51832785 |
| | Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: A nationwide study in Finland | Q57543430 |
| P433 | issue | 5 | |
| P921 | main subject | hospitalization | Q3140971 |
| | osteoporosis | Q165328 |
| P304 | page(s) | 1031-1037 | |
| P577 | publication date | 2016-12-09 | |
| P1433 | published in | Aging Clinical and Experimental Research | Q15754191 |
| P1476 | title | Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey | |
| P478 | volume | 29 | |